A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

New research from the IU School of Medicine found a discovery that could lead to new treatments for prostate cancer. The American Cancer Society said one in eight men will be ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...

The intended therapeutic effect of gonadotropin-releasing-hormone (GnRH) agonists is hypogonadism, which is a leading cause of osteoporosis in men. Observations are consistent with this effect ...

3, 2025 — Much of our knowledge of the protein PD-1, a leading cancer treatment ... Prostate Cancer Cases Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic ...

Jointly Bayer and Orion Corporation-developed NUBEQA (Darolutamide) + Androgen Deprivation Therapy (ADT ... patients with metastatic hormone-sensitive prostate cancer (mHSPC) and will be ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...

Ahead, we’ll dig into what happens when a man is not intimately active, what intimately active really means, why you might be ...

Women tend to live significantly longer than men. For men, the average age of death worldwide is 69.6, but for women it is ...